MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Up 19.5% in December

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a large growth in short interest in December. As of December 31st, there was short interest totaling 74,601 shares, a growth of 19.5% from the December 15th total of 62,429 shares. Based on an average daily volume of 509,578 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 509,578 shares, the days-to-cover ratio is currently 0.1 days.

MediPharm Labs Stock Performance

OTCMKTS:MEDIF opened at $0.05 on Wednesday. MediPharm Labs has a 12 month low of $0.04 and a 12 month high of $0.09. The company’s 50-day moving average price is $0.05 and its two-hundred day moving average price is $0.05.

MediPharm Labs Company Profile

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.